Genetics of autoimmune thyroid disease in the Lebanese population
This study aims to investigate the association of human leukocyte antigen (HLA) class II genes and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) with autoimmune thyroid diseases in the Lebanese population. A total of 128 patients with autoimmune thyroid disease (55 with Graves’ disease (GD) and 73 with Hashimoto’s thyroiditis (HT)) were typed for HLA DQA1 (0301 and 0501) and DQB1 (0201, 0302, and 0303) and for 49A/G CTLA-4 using PCR-based sequence-specific priming methods. A total of 186 matched controls were typed for the same alleles and compared to the diseased population. Results showed no significant differences in HLA DQB1*0201 or DQB1*0301 allelic frequencies or CTLA-4 polymorphisms between patients and controls. For GD, there was a weak association with HLA DQB1*0302 [34.6% (19 of 55) vs. 21.5% (40 of 186), P = 0.048, odds ratio (OR) = 1.926, confidence interval (CI) = 0.999–3.715] and HLA DQB1*0302-DQA1*0501 haplotype [56.36% (31 of 55) vs. 40.8% (76 of 186), P = 0.042, OR = 1.870, CI = 1.018–3.433]. For HT, the frequencies of DQB1*0302-DQA1*0501 haplotype [28.8% (21of 73) vs. 14.5% (27 of 186), P = 0.008, OR = 2.378, CI = 1.241–4.558] and DQB1*0302-DQA1*0301 haplotype [60.2% (44 of 73) vs. 38.7% (72 of 186), P = 0.002, OR = 2.402, CI = 1.381–4.180] were significantly higher in patients. On the other hand, weak association was found between HT and DQA1*0301 allele [32.9% (24 of 73) vs. 20.9% (39 of 186), P = 0.044, OR = 1.846, CI = 1.011–3.373]. Findings show that DQB1*0302-DQA1*0501 and DQB1*0302-DQA1*0301 haplotypes may play a role in the pathogenesis of HT in the Lebanese population. For the 49A/G CTLA-4 polymorphism, no significant difference was found between patients and controls.
KeywordsAutoimmune thyroid disease Graves’ disease Hashimoto’s thyroiditis Human leukocyte antigen Cytotoxic T lymphocyte-associated antigen-4 Thyroid peroxidase antibody
We thank the Lebanese Council for financial support.
Conflict of interest
The authors have no conflicts of interest to disclose.
- Akamizu T, Sale MM, Rich SS, Hiratani H, Noh JY, Kanamoto N, Saijo M, Miyamoto Y, Saito Y, Nakao K, Bowden DW (2000) Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid 10:851–858PubMedCrossRefGoogle Scholar
- Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK (2000) The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves’ disease in African Americans. J Clin Endocrinol Metab 85:1545–1549PubMedCrossRefGoogle Scholar
- De Groot LJ (2005) Diagnosis and treatment of Graves’ disease. In: The thyroid and its diseases. www.thyroidmanager.org/Chapter11/11-frame.htm. Accessed 4 Oct 2011
- Hawkins BR, Lam KS, Ma JT, Wang C, Yeung RT (1987) Strong association between HLA DRw9 and Hashimoto's thyroiditis in southern Chinese. Acta Endocrinol (Copenh) 114:543–546Google Scholar
- Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499PubMedCrossRefGoogle Scholar
- Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP (2007) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 92:3162–3170PubMedCrossRefGoogle Scholar
- Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H (2002) Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. J Clin Endocrinol Metab 87:2593–2596PubMedCrossRefGoogle Scholar
- Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, Tsilipakou M, Fleva A, Gerofotis A, Karadani N, Yovos JG (2009) Major histocompatibility complex class II (DRB1*, DQA1*, and DQB1*) and DRB1*04 subtypes’ associations of Hashimoto’s thyroiditis in a Greek population. Tissue Antigens 73:199–205PubMedCrossRefGoogle Scholar
- Perez C, Scrimshaw NS, Munoz JA (1960) Technique of endemic goitre surveys. In: Endemic goiter, Geneva. Monogr Ser World Health Organ. WHO, Geneva, pp 369–383Google Scholar
- Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, Osborn J, Di Mario U, Buzzetti R (2001) Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11:171–175PubMedCrossRefGoogle Scholar
- Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T (2001) Identification of susceptibility loci for autoimmune thyroid disease to 5q31–q33 and Hashimoto’s thyroiditis to 8q23–q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10:1379–1386PubMedCrossRefGoogle Scholar
- Slatosky J, Shipton B, Wahba H (2000) Thyroiditis: differential diagnosis and management. Am Fam Physician 61(1047–1052):1054Google Scholar
- Weetman AP (1996) Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar’s the thyroid. Lippincott-Raven, Philadelphia, pp 738–748Google Scholar
- WHO/UNICEF/ICCIDD (1994) Indicators for assessing iodine deficiency disorders and their control through salt iodization. WHO/NUT/94.6. WHO, GenevaGoogle Scholar